MSP Recovery, Inc. (NASDAQ: MSPRZ) Stock Competitors & Peer Comparison
See MSPRZ's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MSPRZ and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MSPRZ | $0.04 | +873.17% | 550.4K | N/A | N/A | N/A |
| VEEV | $186.35 | +3.77% | 30.3B | 22.37 | $8.33 | N/A |
| GEHC | $60.58 | -2.27% | 27.6B | 13.29 | $4.56 | +0.23% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $72.83 | +4.28% | 14.3B | 58.80 | $1.24 | N/A |
| BTSGU | $239.76 | +4.13% | 14.2B | 215.44 | $1.11 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $94.64 | +0.32% | 7.9B | 22.11 | $4.28 | N/A |
| TEM | $42.69 | -7.22% | 7.5B | -85.38 | -$0.50 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
MSPRZ vs VEEV Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, VEEV has a market cap of 30.3B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while VEEV trades at $186.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas VEEV's P/E ratio is 22.37. In terms of profitability, MSPRZ's ROE is +1.56%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, MSPRZ is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
MSPRZ vs GEHC Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, GEHC has a market cap of 27.6B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while GEHC trades at $60.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas GEHC's P/E ratio is 13.29. In terms of profitability, MSPRZ's ROE is +1.56%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, MSPRZ is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
MSPRZ vs GEHCV Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas GEHCV's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, MSPRZ is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
MSPRZ vs BTSG Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, BTSG has a market cap of 14.3B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while BTSG trades at $72.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 58.80. In terms of profitability, MSPRZ's ROE is +1.56%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, MSPRZ is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
MSPRZ vs BTSGU Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, BTSGU has a market cap of 14.2B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while BTSGU trades at $239.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas BTSGU's P/E ratio is 215.44. In terms of profitability, MSPRZ's ROE is +1.56%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, MSPRZ is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check BTSGU's competition here
Signify Health, Inc. (NYSE: SGFY)
MSPRZ vs SGFY Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, MSPRZ is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
MSPRZ vs HQY Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, HQY has a market cap of 7.9B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while HQY trades at $94.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 22.11. In terms of profitability, MSPRZ's ROE is +1.56%, compared to HQY's ROE of +0.11%. Regarding short-term risk, MSPRZ is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check HQY's competition here
Tempus AI, Inc. (NASDAQ: TEM)
MSPRZ vs TEM Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, TEM has a market cap of 7.5B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while TEM trades at $42.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas TEM's P/E ratio is -85.38. In terms of profitability, MSPRZ's ROE is +1.56%, compared to TEM's ROE of -0.70%. Regarding short-term risk, MSPRZ is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check TEM's competition here
R1 RCM Inc. (NASDAQ: RCM)
MSPRZ vs RCM Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, RCM has a market cap of 6B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, MSPRZ's ROE is +1.56%, compared to RCM's ROE of +0.00%. Regarding short-term risk, MSPRZ is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
MSPRZ vs TXG Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, TXG has a market cap of 5.9B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while TXG trades at $46.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas TXG's P/E ratio is -272.18. In terms of profitability, MSPRZ's ROE is +1.56%, compared to TXG's ROE of -0.03%. Regarding short-term risk, MSPRZ is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
MSPRZ vs HNGE Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, HNGE has a market cap of 5.8B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while HNGE trades at $74.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas HNGE's P/E ratio is 38.12. In terms of profitability, MSPRZ's ROE is +1.56%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, MSPRZ is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check HNGE's competition here
Doximity, Inc. (NYSE: DOCS)
MSPRZ vs DOCS Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, DOCS has a market cap of 3.8B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while DOCS trades at $20.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 13.35. In terms of profitability, MSPRZ's ROE is +1.56%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, MSPRZ is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
MSPRZ vs ONEM Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, MSPRZ's ROE is +1.56%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, MSPRZ is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
MSPRZ vs PRVA Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, PRVA has a market cap of 3.2B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while PRVA trades at $25.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 159.38. In terms of profitability, MSPRZ's ROE is +1.56%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, MSPRZ is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
MSPRZ vs PGNY Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, PGNY has a market cap of 2.4B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while PGNY trades at $31.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas PGNY's P/E ratio is 22.77. In terms of profitability, MSPRZ's ROE is +1.56%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, MSPRZ is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
MSPRZ vs HTFL Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, HTFL has a market cap of 2.1B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while HTFL trades at $24.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas HTFL's P/E ratio is -12.00. In terms of profitability, MSPRZ's ROE is +1.56%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, MSPRZ is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
MSPRZ vs WGS Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, WGS has a market cap of 1.8B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while WGS trades at $59.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas WGS's P/E ratio is 69.53. In terms of profitability, MSPRZ's ROE is +1.56%, compared to WGS's ROE of -0.28%. Regarding short-term risk, MSPRZ is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check WGS's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
MSPRZ vs NXGN Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, MSPRZ's ROE is +1.56%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, MSPRZ is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check NXGN's competition here
Teladoc Health, Inc. (NYSE: TDOC)
MSPRZ vs TDOC Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, TDOC has a market cap of 1.6B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while TDOC trades at $8.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -9.75. In terms of profitability, MSPRZ's ROE is +1.56%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, MSPRZ is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check TDOC's competition here
Agiliti, Inc. (NYSE: AGTI)
MSPRZ vs AGTI Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, MSPRZ's ROE is +1.56%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, MSPRZ is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
MSPRZ vs OMDA Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, OMDA has a market cap of 1.2B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while OMDA trades at $20.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas OMDA's P/E ratio is 293.29. In terms of profitability, MSPRZ's ROE is +1.56%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, MSPRZ is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check OMDA's competition here
Certara, Inc. (NASDAQ: CERT)
MSPRZ vs CERT Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, CERT has a market cap of 1.2B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while CERT trades at $7.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas CERT's P/E ratio is 19.26. In terms of profitability, MSPRZ's ROE is +1.56%, compared to CERT's ROE of -0.01%. Regarding short-term risk, MSPRZ is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
MSPRZ vs GDRX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, GDRX has a market cap of 1B. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while GDRX trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 8.97. In terms of profitability, MSPRZ's ROE is +1.56%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, MSPRZ is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check GDRX's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
MSPRZ vs CCLDO Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, MSPRZ is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
MSPRZ vs HSTM Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, HSTM has a market cap of 792.8M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while HSTM trades at $27.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 35.70. In terms of profitability, MSPRZ's ROE is +1.56%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, MSPRZ is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
MSPRZ vs PHR Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, PHR has a market cap of 632.6M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while PHR trades at $10.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas PHR's P/E ratio is 36.55. In terms of profitability, MSPRZ's ROE is +1.56%, compared to PHR's ROE of +0.03%. Regarding short-term risk, MSPRZ is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
MSPRZ vs MPLN-WT Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, MSPRZ is more volatile compared to MPLN-WT. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
MSPRZ vs ACCD Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, MSPRZ's ROE is +1.56%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, MSPRZ is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
MSPRZ vs SHCR Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, MSPRZ is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SHCR's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
MSPRZ vs WGSWW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas WGSWW's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, MSPRZ is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for MSPRZ.Check WGSWW's competition here
Evolent Health, Inc. (NYSE: EVH)
MSPRZ vs EVH Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, EVH has a market cap of 474.7M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while EVH trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas EVH's P/E ratio is 422.00. In terms of profitability, MSPRZ's ROE is +1.56%, compared to EVH's ROE of -0.78%. Regarding short-term risk, MSPRZ is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check EVH's competition here
NRC Health (NASDAQ: NRC)
MSPRZ vs NRC Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, NRC has a market cap of 474.2M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while NRC trades at $21.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 25.66. In terms of profitability, MSPRZ's ROE is +1.56%, compared to NRC's ROE of +0.57%. Regarding short-term risk, MSPRZ is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
MSPRZ vs SLGC Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, MSPRZ is more volatile compared to SLGC. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
MSPRZ vs SLGCW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, MSPRZ is more volatile compared to SLGCW. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
MSPRZ vs TBRG Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is 9.37. In terms of profitability, MSPRZ's ROE is +1.56%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, MSPRZ is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check TBRG's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
MSPRZ vs SOPH Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SOPH has a market cap of 393.2M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SOPH trades at $5.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -11.00. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, MSPRZ is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN)
MSPRZ vs MPLN Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, MSPRZ's ROE is +1.56%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, MSPRZ is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
MSPRZ vs SLP Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SLP has a market cap of 370.9M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SLP trades at $18.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SLP's P/E ratio is 20.84. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SLP's ROE of +0.06%. Regarding short-term risk, MSPRZ is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SLP's competition here
Claritev Corporation (NYSE: CTEV)
MSPRZ vs CTEV Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, CTEV has a market cap of 369.3M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while CTEV trades at $21.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -1.66. In terms of profitability, MSPRZ's ROE is +1.56%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, MSPRZ is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check CTEV's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
MSPRZ vs TRHC Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, MSPRZ's ROE is +1.56%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, MSPRZ is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check TRHC's competition here
So-Young International Inc. (NASDAQ: SY)
MSPRZ vs SY Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SY has a market cap of 253.2M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SY trades at $1.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SY's P/E ratio is -5.85. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SY's ROE of -0.16%. Regarding short-term risk, MSPRZ is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SY's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
MSPRZ vs SMFR Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SMFR's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, MSPRZ is more volatile compared to SMFR. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
MSPRZ vs SPOK Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SPOK has a market cap of 221.2M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SPOK trades at $10.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 17.65. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, MSPRZ is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
MSPRZ vs AMWL Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, AMWL has a market cap of 179.4M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while AMWL trades at $10.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -2.07. In terms of profitability, MSPRZ's ROE is +1.56%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, MSPRZ is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
MSPRZ vs HCAT Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, HCAT has a market cap of 153.7M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while HCAT trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is 10.40. In terms of profitability, MSPRZ's ROE is +1.56%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, MSPRZ is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
MSPRZ vs CPSI Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, MSPRZ's ROE is +1.56%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, MSPRZ is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
MSPRZ vs OPRX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, OPRX has a market cap of 117.1M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while OPRX trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is 5.72. In terms of profitability, MSPRZ's ROE is +1.56%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, MSPRZ is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
MSPRZ vs AUGX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, MSPRZ's ROE is +1.56%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, MSPRZ is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
MSPRZ vs CCLD Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, CCLD has a market cap of 94.3M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while CCLD trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is 8.22. In terms of profitability, MSPRZ's ROE is +1.56%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, MSPRZ is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
MSPRZ vs DH Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, DH has a market cap of 72.4M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while DH trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas DH's P/E ratio is 2.64. In terms of profitability, MSPRZ's ROE is +1.56%, compared to DH's ROE of -0.67%. Regarding short-term risk, MSPRZ is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
MSPRZ vs FORA Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -24.11. In terms of profitability, MSPRZ's ROE is +1.56%, compared to FORA's ROE of -0.17%. Regarding short-term risk, MSPRZ is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
MSPRZ vs CCLDP Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas CCLDP's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, MSPRZ is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
MSPRZ vs ONMD Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, ONMD has a market cap of 35M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while ONMD trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -4.10. In terms of profitability, MSPRZ's ROE is +1.56%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, MSPRZ is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
MSPRZ vs SNCE Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, MSPRZ is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
MSPRZ vs AKLI Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, MSPRZ's ROE is +1.56%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, MSPRZ is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
MSPRZ vs SHLT Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -3.87. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, MSPRZ is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
MSPRZ vs SHCRW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, MSPRZ is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SHCRW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
MSPRZ vs EUDA Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, EUDA has a market cap of 28M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while EUDA trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas EUDA's P/E ratio is -28.30. In terms of profitability, MSPRZ's ROE is +1.56%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, MSPRZ is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check EUDA's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
MSPRZ vs ONMDW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, ONMDW has a market cap of 27.8M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas ONMDW's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, MSPRZ is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
MSPRZ vs STRM Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -2.40. In terms of profitability, MSPRZ's ROE is +1.56%, compared to STRM's ROE of -0.32%. Regarding short-term risk, MSPRZ is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
MSPRZ vs RNLX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, MSPRZ's ROE is +1.56%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, MSPRZ is more volatile compared to RNLX. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
MSPRZ vs LIFW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, MSPRZ's ROE is +1.56%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, MSPRZ is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check LIFW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
MSPRZ vs BEATW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, BEATW has a market cap of 15.9M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while BEATW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas BEATW's P/E ratio is -0.04. In terms of profitability, MSPRZ's ROE is +1.56%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, MSPRZ is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for MSPRZ.Check BEATW's competition here
Babylon Holdings Limited (NYSE: BBLN)
MSPRZ vs BBLN Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, MSPRZ's ROE is +1.56%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, MSPRZ is more volatile compared to BBLN. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
MSPRZ vs ETAO Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, MSPRZ's ROE is +1.56%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, MSPRZ is more volatile compared to ETAO. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
MSPRZ vs BFRG Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, BFRG has a market cap of 7.1M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while BFRG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -1.12. In terms of profitability, MSPRZ's ROE is +1.56%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, MSPRZ is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check BFRG's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
MSPRZ vs SCNX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SCNX has a market cap of 5.7M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SCNX trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SCNX's P/E ratio is -0.15. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, MSPRZ is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
MSPRZ vs UPH Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, MSPRZ's ROE is +1.56%, compared to UPH's ROE of -1.05%. Regarding short-term risk, MSPRZ is more volatile compared to UPH. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
MSPRZ vs UPH-WT Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, MSPRZ is more volatile compared to UPH-WT. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
MSPRZ vs MGRX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, MGRX has a market cap of 5.3M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while MGRX trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.39. In terms of profitability, MSPRZ's ROE is +1.56%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, MSPRZ is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
MSPRZ vs PEARW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, MSPRZ's ROE is +1.56%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, MSPRZ is more volatile compared to PEARW. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
MSPRZ vs PEAR Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, MSPRZ's ROE is +1.56%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, MSPRZ is more volatile compared to PEAR. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check PEAR's competition here
Ontrak, Inc. (NASDAQ: OTRK)
MSPRZ vs OTRK Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.02. In terms of profitability, MSPRZ's ROE is +1.56%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, MSPRZ is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
MSPRZ vs HCTI Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, HCTI has a market cap of 1.9M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while HCTI trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.21. In terms of profitability, MSPRZ's ROE is +1.56%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, MSPRZ is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
MSPRZ vs CMAX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, MSPRZ's ROE is +1.56%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, MSPRZ is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check CMAX's competition here
Aclarion, Inc. (NASDAQ: ACON)
MSPRZ vs ACON Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while ACON trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas ACON's P/E ratio is -0.23. In terms of profitability, MSPRZ's ROE is +1.56%, compared to ACON's ROE of -0.54%. Regarding short-term risk, MSPRZ is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check ACON's competition here
VSee Health, Inc. (NASDAQ: VSEE)
MSPRZ vs VSEE Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, VSEE has a market cap of 1.3M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while VSEE trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -0.15. In terms of profitability, MSPRZ's ROE is +1.56%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, MSPRZ is more volatile compared to VSEE. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check VSEE's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
MSPRZ vs VSEEW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, VSEEW has a market cap of 1.3M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, MSPRZ's ROE is +1.56%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, MSPRZ is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
MSPRZ vs LIFWZ Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, MSPRZ is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
MSPRZ vs EUDAW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, EUDAW has a market cap of 922.5K. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, MSPRZ's ROE is +1.56%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, MSPRZ is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
MSPRZ vs WORX Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, WORX has a market cap of 629.5K. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while WORX trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -0.69. In terms of profitability, MSPRZ's ROE is +1.56%, compared to WORX's ROE of -0.65%. Regarding short-term risk, MSPRZ is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check WORX's competition here
Akerna Corp. (NASDAQ: KERN)
MSPRZ vs KERN Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, MSPRZ's ROE is +1.56%, compared to KERN's ROE of -0.17%. Regarding short-term risk, MSPRZ is more volatile compared to KERN. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
MSPRZ vs KERNW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, MSPRZ's ROE is +1.56%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, MSPRZ is more volatile compared to KERNW. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
MSPRZ vs LIFWW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, MSPRZ is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
MSPRZ vs ZCMD Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, ZCMD has a market cap of 48.6K. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while ZCMD trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -0.05. In terms of profitability, MSPRZ's ROE is +1.56%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, MSPRZ is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
MSPRZ vs CMAXW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, MSPRZ is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
MSPRZ vs ACONW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, ACONW has a market cap of 11.9K. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas ACONW's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, MSPRZ is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check ACONW's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
MSPRZ vs SMFRW Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas SMFRW's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to SMFRW's ROE of -0.28%. Regarding short-term risk, MSPRZ is more volatile compared to SMFRW. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check SMFRW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
MSPRZ vs MTBCO Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas MTBCO's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, MSPRZ is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
MSPRZ vs MSPRV Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas MSPRV's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to MSPRV's ROE of N/A. Regarding short-term risk, MSPRZ is more volatile compared to MSPRV. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check MSPRV's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
MSPRZ vs CNVY Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, CNVY has a market cap of 0. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas CNVY's P/E ratio is -71.50. In terms of profitability, MSPRZ's ROE is +1.56%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, MSPRZ is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check CNVY's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
MSPRZ vs MTBCP Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas MTBCP's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, MSPRZ is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
MSPRZ vs MTBC Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, MTBC has a market cap of 0. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas MTBC's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, MSPRZ is more volatile compared to MTBC. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
MSPRZ vs CHNG Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, CHNG has a market cap of 0. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas CHNG's P/E ratio is -152.72. In terms of profitability, MSPRZ's ROE is +1.56%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, MSPRZ is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check CHNG's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
MSPRZ vs IMS Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, IMS has a market cap of 0. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas IMS's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to IMS's ROE of +0.27%. Regarding short-term risk, MSPRZ is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check IMS's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
MSPRZ vs KURIU Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, KURIU has a market cap of 0. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas KURIU's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, MSPRZ is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check KURIU's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
MSPRZ vs CHNGU Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas CHNGU's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, MSPRZ is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check CHNGU's competition here
Cue Health Inc. (NASDAQ: HLTH)
MSPRZ vs HLTH Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, HLTH has a market cap of 0. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while HLTH trades at $25.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas HLTH's P/E ratio is N/A. In terms of profitability, MSPRZ's ROE is +1.56%, compared to HLTH's ROE of +0.00%. Regarding short-term risk, MSPRZ is more volatile compared to HLTH. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check HLTH's competition here
NantHealth, Inc. (NASDAQ: NH)
MSPRZ vs NH Comparison July 2026
MSP Recovery, Inc. (NASDAQ: MSPRZ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPRZ stands at 550.4K. In comparison, NH has a market cap of 0. Regarding current trading prices, MSPRZ is priced at $0.04 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPRZ currently has a P/E ratio of N/A, whereas NH's P/E ratio is -0.12. In terms of profitability, MSPRZ's ROE is +1.56%, compared to NH's ROE of +0.35%. Regarding short-term risk, MSPRZ is more volatile compared to NH. This indicates higher risk in terms of short-term price fluctuations for MSPRZ.Check NH's competition here